Because the PI3K-AKT-mTOR pathway has been shown to control tumour development and lipid synthesis, we tested whether HIF-2α affects PI3K-AKT-mTOR signalling in steatotic HCC cells. The gene discussed is EPAS1; the disease is hepatocellular carcinoma.